Biogen Molecules Private Limited - Company Profile

It is a trading private limited company based in Giridih, Jharkhand, India, established in 2015.
2015 Giridih, Jharkhand, India Struck Off
Last Updated:
About Biogen Molecules Private Limited

Biogen Molecules Private Limited, a struck off private limited company, was established on 15 October 2015 in Giridih, Jharkhand, India. Engaging in retailers within the trading sector, it holds CIN: U51397JH2015PTC003220. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.

It upholds a active non-compliant status. Its leadership includes Prakash Mahto (Director), Vikas Kumar (Director). Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 1St Floor House No. 44, High School Road Pachamba, Giridih, Jharkhand, 815316.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397JH2015PTC003220

  • Registration Number

    003220

  • Incorporation Date

    15 October 2015

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Biogen Molecules Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biogen Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Biogen Molecules Private Limited?
Current Directors
Name Designation Appointment Date Status
Prakash Mahto Director 15 Oct 2015 Current
Vikas Kumar Director 15 Oct 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biogen Molecules.

Enhance accessibility to Biogen Molecules's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Biogen Molecules revenue growth over time
Biogen Molecules profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biogen Molecules?

In 2016, Biogen Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Biogen Molecules?

Unlock and access historical data on people associated with Biogen Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biogen Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogen Molecules's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biogen Molecules
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Biogen Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Biogen Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ranchi. was completed.

  • Director Appointment

    The activity Prakash Mahto was appointed as a Director was appointed as a Director on 15 Oct 2015 & has been associated with this company since 10 years 3 months . was completed.

  • Director Appointment

    The activity Vikas Kumar was appointed as a Director was appointed as a Director on 15 Oct 2015 & has been associated with this company since 10 years 3 months . was completed.

  • Company Incorporation

    The activity Biogen Molecules Private Limited was registered on 15 Oct 2015 with Roc Ranchi & aged 10 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biogen Molecules Private Limited?

The CIN of Biogen Molecules Private Limited is U51397JH2015PTC003220.

Where is Biogen Molecules Private Limited headquartered?

Biogen Molecules Private Limited is headquartered at 1St Floor House No. 44, High School Road Pachamba, Giridih, Jharkhand, 815316.

When was Biogen Molecules Private Limited incorporated?

Biogen Molecules Private Limited was incorporated on 15 October 2015.

Who are the current directors of Biogen Molecules Private Limited?

The current directors of Biogen Molecules Private Limited are

What is the primary industry of Biogen Molecules Private Limited?

The primary industry of Biogen Molecules Private Limited is Trading.

Is Biogen Molecules Private Limited a listed company?

Biogen Molecules Private Limited is unlisted.

What is the capital structure of Biogen Molecules Private Limited?

The authorized capital of Biogen Molecules Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Biogen Molecules Private Limited?

The compliance status of Biogen Molecules Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available